WITHDRAWN: Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group.
The publisher regrets that this is an accidental duplication of an article that has already been published in The Breast, 12 (2003) 42-50, doi:10.1016/S0960-9776(02)00180-7. The duplicate article has therefore been withdrawn.